Studies have demonstrated that inflammatory characteristics of asthma may be related to the release of Th2 cytokines (IL-4, IL-5, IL-13 and IL-33) mediated by the regulation of arachidonic acid metabolic pathway (17, 18, 47). This evidence concerns the gene IL33 and asthma.